Related Experiment Video
Updated: Jan 12, 2026
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
TM4SF1 as a Prognostic Biomarker and Therapeutic Target in Cervical Cancer
Jue-Xiao Deng1, Lan-Yue Zhang1, Zhu-Qing Ouyang1
1Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Transmembrane 4 L6 family member 1 (TM4SF1) is overexpressed in cervical cancer, correlating with poor prognosis. TM4SF1 may be a therapeutic target and prognostic biomarker for cervical cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genomics
Background:
- Transmembrane 4 L6 family member 1 (TM4SF1) is implicated in various cancers.
- Limited research exists on TM4SF1's role in cervical cancer.
- Understanding TM4SF1 is crucial for cervical cancer research.
Purpose of the Study:
- Evaluate TM4SF1's prognostic value in cervical cancer.
- Investigate TM4SF1's oncogenic functions.
- Explore TM4SF1 as a therapeutic target.
Main Methods:
- Analyzed TCGA data for TM4SF1 expression and patient outcomes.
- Utilized Wilcoxon rank-sum test and Kaplan-Meier analysis.
- Performed functional enrichment, methylation analysis, and in vitro experiments.
Main Results:
- TM4SF1 overexpression linked to poor cervical cancer prognosis.
- TM4SF1 correlates with immune cell infiltration and checkpoint genes.
- TM4SF1 knockdown inhibited migration, invasion, EMT, and promoted apoptosis in cervical cancer cells.
Conclusions:
- TM4SF1 shows potential as a prognostic biomarker.
- TM4SF1 may be a viable therapeutic target for cervical cancer.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
